share_log

Craig-Hallum Maintains Buy on BioLife Solns, Lowers Price Target to $23

Craig-Hallum Maintains Buy on BioLife Solns, Lowers Price Target to $23

Craig-Hallum 维持对 BioLife Solns 的买入,将目标股价下调至 23 美元
Benzinga ·  2023/08/10 15:43

Craig-Hallum analyst Matt Hewitt maintains BioLife Solns (NASDAQ:BLFS) with a Buy and lowers the price target from $29 to $23.

Craig-Hallum分析师马特·休伊特维持生物生命Solns(纳斯达克:BLFS)的买入,并将目标价从29美元下调至23美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发